
MRL-Lpr
- ¥200 - 350
- 红斑狼疮模型小鼠
- 江苏常州
- 2026年03月23日
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 提供商:
卡文斯
- 规格:
3-8周/对照组3-8周
| 规格: | 3-8周 | 产品价格: | ¥350.0 |
|---|---|---|---|
| 规格: | 对照组3-8周 | 产品价格: | ¥200.0 |
品系编号:C000117
品系背景:MRL/MpJ
突变基因:Fas
品系描述:MRL/lpr 小鼠是被广泛认可的人类 SLE 小鼠模型。携带凋亡相关Fas基因突变的MRL/lpr小鼠会自发严重的自身免疫性疾病,该疾病与SLE患者的许多特征相似。如SLE患者所表现的那样,MRL/lpr小鼠在多个组织(器官)有炎症,包括关节、肌肉、血管、肾脏、大脑和周围神经。纯合子小鼠表现为系统性自身免疫、与异常T细胞增殖相关的大量淋巴结病、关节炎和免疫复合性肾小球肾炎。从大约三个月大开始,MRL-lpr/lpr小鼠的循环免疫复合物水平显著升高,而MRL正常小鼠的循环免疫复合物水平却没有升高。雌性纯合子小鼠平均17周龄死亡,雄性22周龄死亡。而在C57BL/6J或C3H/HeJ背景下,雌性纯合子小鼠的寿命是42周和52周。
应用领域:MRL/lpr 小鼠表型特征为自体淋巴结过度增生,是用于研究风湿性关节炎及全身性红斑性狼疮的模式动物。往往死于慢性肾小球肾炎,雌性比雄性早发病。
该小鼠是系统性红斑狼疮样自身免疫综合征的模型。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验1. Liu Y, Wang X, Huang M, Luo A, Liu S, Cai M, Li W, Yuan S, Zheng Z, Liu X, Tang C. METTL3 facilitates kidney injury through promoting IRF4-mediated plasma cell infiltration via an m6A-dependent manner in systemic lupus erythematosus. BMC Med. 2024 Nov 5;22(1):511.
2. Pan X, Chen S, Shen R, Liu S, You Y. HOXA11-OS participates in lupus nephritis by targeting miR-124-3p mediating Cyr61 to regulate podocyte autophagy. Mol Med. 2022 Nov 22;28(1):138.
The MRL Model: An Invaluable Tool in Studies of AutoimmunityBrain Interactions
, and neuropsychiatric manifestations. By documenting autoimmunity-associated neuronal degeneration and cytotoxicity of the cerebrospinal fluid from disease-affected subjects, the murine MRL model had shown high validity in revealing principal pathogenic circuits
Mannosylated and Histidylated LPR Technology for Vaccination with Tumor Antigen mRNA
antigen including better delivery and security. In this chapter, we report the preparation of mannosylated mRNA nanoparticles termed mannosylated lipopolyplexes or Man-LPR loaded with mRNA encoding a melanoma antigen. This formulation enhances
Generation of Self-Peptides to Treat Systemic Lupus Erythematosus
, their capacity to lower peripheral cell hyperproliferation in lupus-prone MRL/lpr mice, and, as a final step, their ability to slow down the development of lupus disease in model animals.
技术资料暂无技术资料 索取技术资料










